1. Home
  2. OSIS vs AKRO Comparison

OSIS vs AKRO Comparison

Compare OSIS & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSI Systems Inc. (DE)

OSIS

OSI Systems Inc. (DE)

HOLD

Current Price

$265.94

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.53

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSIS
AKRO
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.5B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
OSIS
AKRO
Price
$265.94
$54.53
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$268.67
$73.56
AVG Volume (30 Days)
338.4K
1.7M
Earning Date
01-22-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
14.72
N/A
EPS
8.81
N/A
Revenue
$1,753,782,000.00
N/A
Revenue This Year
$9.62
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
$30.18
N/A
Revenue Growth
9.37
N/A
52 Week Low
$150.84
$21.34
52 Week High
$292.34
$58.40

Technical Indicators

Market Signals
Indicator
OSIS
AKRO
Relative Strength Index (RSI) 51.38 66.54
Support Level $264.78 $54.22
Resistance Level $275.65 $54.70
Average True Range (ATR) 12.05 0.14
MACD 0.17 -0.11
Stochastic Oscillator 77.93 64.18

Price Performance

Historical Comparison
OSIS
AKRO

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: